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The circadian clock, which governs metabolic and physiological rhythms in diverse organ-
isms, shares common features with the cell cycle. Yet, these two oscillatory systems seem 
to be fully independent of each other. Recent studies now reveal that some essential regu-
latory elements are common to both the cell cycle and circadian clock.How do cells sense time? What is the right time to grow, 
divide, or die? Each of these events has a specific phase, 
and cells seem to know how to anticipate them by using 
an intrinsic timing system. Within each cell, however, at 
least two clocks coexist, one devoted to the control of 
cell division and the other that acts as a circadian pace-
maker. Are these two systems connected to each other? 
The cell division of some unicellular organisms, such as 
the green alga Chlamydomonas reinhardtii, the flagellate 
Euglena gracilis, the cyanobacterium Synechococcus 
elongates, and the dinoflagellate Gonyaulax polyedra, 
can be timed by a circadian mechanism. Obviously, the 
situation in multicellular organisms is much more com-
plicated, as the timetable of physiological events and cell 
division is not synchronous among various tissues. Yet, 
increasing evidence in mammals reveals that these two 
intracellular timing devices, although classically thought 
to be independent, share some intriguing links.
Common Pathways to Rhythmicity
At the molecular level, circadian clocks are composed 
of the products of “clock genes” organized in a complex 
transcriptional-translational regulatory network (Dunlap, 
1999). Some clock genes encode transcriptional activa-
tors, others encode proteins able to feedback and inhibit 
their own expression. Cells experience daily variations in 
the levels of clock proteins and interpret these changes 
to reflect different phases of the daily cycle. As a general 
feature, molecular pacemakers operate to anticipate the 
needs of the organisms through the cyclic regulation of 
clock-controlled genes.
One of the discoveries that has deeply affected the 
field of circadian biology during the past ten years is 
that intrinsic oscillators are present in most peripheral 
tissues, a property recognized in Drosophila, zebrafish, 
and mammals (Schibler and Sassone-Corsi, 2002). In 
mammals, the subsidiary oscillators located in periph-
eral tissues are thought to be hierarchically coordi-
nated by the master pacemaker, located in a region of 
the hypothalamus called the suprachiasmatic nucleus (SCN) containing 10–15,000 neurons. This finding sig-
nificantly extended our view of circadian organization 
at the whole-organism level. Additional evidence dem-
onstrated the presence of circadian oscillators even in 
established cell lines: in cultured fibroblasts the endog-
enous clock system needs a simple serum shock to be 
resynchronized, whereas the pacemaker of zebrafish 
embryonic cells starts ticking upon exposure to a short 
pulse of light. Overall, these results emphasize that cir-
cadian clock functions are not the domain of SCN neu-
rons, as thought for decades, but instead are common 
features of most cells (Nagoshi et al., 2004). This evi-
dence alone emphasizes the appealing kinship between 
the cell cycle and the circadian clock.
Importantly, the molecular architecture of the circa-
dian system shares some striking similarities with the 
intricate machinery that governs cell division. Both the 
cell cycle and the circadian oscillator are intracellular 
“clocks” that rely on sequential phases of transcription-
translation and protein modification and degradation. 
Both are based on the conceptual device of interlocked 
autoregulatory loops. The question of whether these two 
intracellular clock systems have evolved in a concerted 
manner is thereby justified. Is it only accidental that most 
eukaryotic cells in culture undergo division with a perio-
dicity of roughly one day? As it is conceivable that some 
millions of years ago most cells were sensitive to light-
dark cycles, we can surmise that what we study today 
as the “cell cycle” represents a vestigial circadian clock 
(Klevecz, 1984). This idea is particularly tantalizing when 
one takes into account that the expression of several 
mammalian cell-cycle genes—including c-myc, Cyclin-
D1, and Wee-1—is regulated in a circadian manner.
A pivotal position in the transcription/translation-
based autoregulatory feedback loops that constitute 
the circadian clock machinery in animals is occupied by 
CLOCK, a basic helix-loop-helix-Per/Arnt/Sim (bHLH-
PAS) transcription factor. CLOCK acts as master regula-
tor serving as a positive element in the core feedback 
loop. The recent finding that CLOCK acts as a histone Cell 129, May 4, 2007 ©2007 Elsevier Inc. 461
acetyltransferase (HAT) and thereby enzymatically influ-
ences chromatin remodeling (Doi et al., 2006) furthers 
strengthen the importance of this protein as pivotal 
element in global circadian control. A likely scenario 
involves chromatin conformational changes that would 
occur specifically and efficiently at predetermined 
genomic loci. In mammals, CLOCK heterodimerizes with 
the BMAL1 protein and promotes transcription of other 
essential clock genes, such as Period (Per1, Per2, and 
Per3) and Cryptochrome (Cry1 and Cry2) genes. mPER 
and mCRY proteins then negatively feedback to repress 
their own transcription by acting on the CLOCK:BMAL1 
complex. This same regulatory loop also drives directly 
or indirectly the rhythmic expression of most clock-con-
trolled genes. Systematic surveys have demonstrated 
that 10% of all mammalian mRNA transcripts in various 
tissues, including the liver and the SCN, oscillate in their 
abundance (Panda et al., 2002). Interestingly, several of 
these oscillating transcripts are known to be involved in 
tissue homeostasis, cellular metabolism, and regula-
tion of the cell cycle, a notion that nicely fits previous 
observations of human cells demonstrating striking cir-
cadian variations in DNA synthesis and mitotic division 
(Klevecz, 1984).
The Prominent Position of the E Box
E box regulatory elements are the common hallmark of 
the promoters of clock-controlled genes and various 
cell-cycle genes in mammals. CLOCK:BMAL1 recognize 
the E box and exert transcriptional activation through 
binding to this site. It is noteworthy that a number of 
cell-cycle genes involved in either G2-M or G1-S transi-
tions contain E boxes in their promoters. One cell-cycle 
gene that is under direct CLOCK:BMAL1 control is Wee-
1, whose promoter contains three E boxes (Matsuo et 
al., 2003; Hirayama et al., 2005). This gene encodes a 
protein kinase that phosphorylates and thereby inacti-
vates the CDC2/Cyclin B1 complex, an event that delays 
or prevents entry into mitosis. WEE-1 circadian levels 
robustly oscillate in the mammalian liver, being coordi-
nately regulated with clock genes, even though there is 
normally little cell proliferation in this organ. Strikingly, 
however, liver regeneration induced by partial hepatec-
tomy—a system that allows the study of cell-cycle con-
trol in vivo—is drastically impaired in arrhythmic mice 
carrying a mutation in the Cry clock genes (Matsuo et 
al., 2003). The proteins encoded by Cry1 and Cry2 par-
ticipate in the core clock mechanism by inhibiting the 
positive action of CLOCK:BMAL1. Although the molec-
ular mechanism of this repression is yet unclear, it is 
intriguing that mouse cryptochromes CRY1 and CRY2 
were discovered by accident because of their structural 
similarity to the photolyases, proteins involved in the 
repair of UV-damaged DNA. Although there is no bio-
chemical evidence of participation in DNA repair, one 
additional feature of the CRYs may be revealing: efficient 
repression of CLOCK:BMAL1-mediated transcription is 
obtained prior to the interaction of CRYs with PER pro-462 Cell 129, May 4, 2007 ©2007 Elsevier Inc.teins. As reported below, this characteristic may have 
important implications as it establishes another tantaliz-
ing link with the cell cycle.
Revealing Interactions
Proteins encoded by the per genes contribute in various 
ways to the core clock mechanism. PER and CRY pro-
teins interact in the cytoplasm and then enter the nucleus 
to inhibit CLOCK:BMAL1 activity and consequently the 
expression of the per genes, thereby constituting the 
primary autoregulatory feedback loop. Alterations of the 
rhythmic expression of PER proteins predictably disturb 
the circadian cycle. Less predictably, overexpression 
of PER1 increases the sensitivity of human cancer cells 
to DNA-damage-induced apoptosis, whereas inhibi-
tion of PER1 has the opposite effect: it inhibits apop-
tosis. This finding unveiled some unsuspected links of 
PER1 with cellular components that operate as key ele-
ments in the control of cell growth and DNA damage. 
Specifically, PER1 was found to interact with the ATM 
(ataxia-telangiectasia mutated), a kinase involved in the 
cellular response to ionizing radiations and DNA double-
strand-break-inducing events. ATM phosphorylates the 
cohesin SMC1, p53, and the checkpoint kinase Chk2. 
Consistently, Chk2 was also found to be associated with 
PER1-ATM (Gery et al., 2006). Thus, it would appear that 
PER1 antagonizes the cell cycle in an oscillatory fashion 
similar to the manner in which it antagonizes the func-
tion of CLOCK:BMAL1. Relevant in this respect is the 
observation that per-1 expression is downregulated in 
human tumors, whereas ectopic PER1 decreases the 
levels of Wee-1, Cyclin B1, and cdc2 expression (Gery et 
al., 2006). Finally, it is also notable that CLOCK:BMAL1 
regulate the expression of the cMYC oncoprotein, which 
cooperates with ATM in promoting apoptosis and sup-
pressing tumorigenesis.
These findings in the mammalian system have an imme-
diate counterpart in Neurospora, a fungus that has been 
successfully used in circadian studies (Dunlap, 1999). 
Recent data demonstrate that the kinase PRD4—the 
equivalent of mammalian Chk2—interacts with the central 
clock factor in Neurospora, FRQ, inducing its phosphor-
ylation (Pregueiro et al., 2006). As the role of FRQ paral-
lels the one of PER1 in mammals, it would seem that some 
degree of evolutionary conservation exist in the functional 
coupling between circadian clock and cell cycle. The case 
of PRD4 is paradigmatic given that it is a clock-controlled 
gene, thereby completing a loop between cell-cycle and 
clock transcriptional control. An attractive aspect of this 
study is that PRD4 seems to function as the mediator of 
the effect that the DNA-damaging agent methylmethane 
sulfonate (MMS) has on the phase of the circadian rhythm 
(Pregueiro et al., 2006). Thus, PRD4 (and possibly Chk2 
in mammals) appears to intervene in the regulatory clock 
loops specifically in response to DNA damage.
Another clock protein, TIM, is the natural partner of 
PER in Drosophila. tim null mice display developmen-
tal arrest, a phenotype that had convinced researchers 
that TIM would not function as a bona fide clock gene 
in the mouse. Definitive demonstration of a direct role 
for TIM in the clock core mechanism came by condi-
tional knockdown of TIM protein expression in the SCN 
(Barnes et al., 2003). Further evidence indicates that 
TIM is also directly implicated in cell-cycle control. Strik-
ingly, TIM was found in a complex that includes the 
ATM-related kinase ATR and ATRIP, a substrate of ATR 
(Unsal-Kacmaz et al., 2005). Intriguingly, recent results 
indicate that these same components of the S phase 
checkpoint interact with HCLK2, a yet uncharacterized 
orphan mammalian protein with weak similarity to the 
C. elegans biological clock protein CLK-2 (Collis et al., 
2007). It would seem then that HCLK2 may play a critical 
role in the S phase checkpoint and the following activa-
tion of cellular repair responses.
All together these findings seem to indicate that two 
essential clock elements—PER1 and TIM—function-
ally interplay with two closely related kinases, ATM 
and ATR, which operate at essential control steps of 
the cellular response to ionizing radiations and DNA 
double-strand-break-inducing events. The anal-
ogy between PER1 and TIM extends to checkpoint 
kinases: PER1 interacts with Chk2 and TIM inter-
acts with Chk1. Although structurally very different, 
Chk1 and Chk2 phosphorylate a number of common 
substrates and have partly overlapping roles. Impor-
tantly, the upstream elements of checkpoint pathways 
include ATM and ATR, which principally phosphor-
ylate and activate the effector kinases Chk2 and Chk1, 
respectively.
The ensemble of these studies depicts a scenario 
where various pathways of circadian regulation converge 
into a possibly concerted cellular clock response to DNA 
damage (Figure 1). Far-reaching implications include the 
use of clock intracellular systems as ways to compre-
hend the physiological response to DNA damage and 
the design of alternative pharmacological strategies.
Circadian Checkpoints?
The concept of “checkpoint” in the cell cycle is well 
established and has shaped the interpretation of vari-
ous control pathways (Doree and Hunt, 2002). Nothing 
of the kind has been proposed for the circadian clock. 
Is this because such checkpoints simply do not exist in 
the circadian cycle or because they are hard to identify? 
All the results favor a view of an “opportunistic” connec-
tion between the two cellular cycles, in which the use 
of circadian molecules in cell-cycle control would occur 
under occasional and contingent physiological circum-
stances, such as the cellular response to a genotoxic 
stress. It is important to stress that mutation of critical 
clock genes, such as the double mutation of Per1 and 
Per2, may result in alteration in the timing of cell divi-
sion (Fu et al., 2005). The reverse situation appears dif-
ferent: to date no behavioral circadian phenotype has 
been associated with in vivo mutations in mammalian 
cell-cycle genes.An interesting clue on how clock genes may influence 
cellular checkpoints came from the observation that the 
expression of mPer1, mPer2, Clock, Cry1, and Bmal1 is 
induced in the liver of mice that undergo exposure to γ 
radiation (Fu et al., 2002). Strikingly, induction is absent 
in mPer2 mutant mice, suggesting a role of the PER2 
protein in the cellular pathways that govern the response 
to stress. The PER2 protein participates in the core circa-
dian clock mechanism, and its ablation results in animals 
deficient in clock function. The same mutant mice were 
found to be cancer prone, showing a significant increase 
in the frequency of spontaneous salivary gland hyper-
plasia and a drastic increased sensitivity to γ radiation 
and tumor development (Fu et al., 2002). This phenotype 
appears to be directly coupled to genes involved in cell 
proliferation and tumor suppression, in particular Cyclin 
D1, Cyclin A, Mdm-2, and GADD45a, whose expression 
displays a circadian pattern that is deregulated in the 
mPer2 mutant mice. Specifically, the oscillatory expres-
sion of c-myc is abolished in mPer2 mutant mice, which 
could then result in alteration of p53 function. Although 
Figure 1. Multiple Connections between the Cell Cycle and 
the Circadian Clock
The CLOCK:BMAL1 heterodimer transcriptionally activates genes 
with E boxes in their regulatory regions, including clock genes and 
cell-cycle genes. Specifically, activation of the gene encoding the 
WEE-1 kinase may result in phosphorylation of the CDC2/Cyclin B1 
complex and control of the G2-M transition. Transcriptional induction 
by CLOCK:BMAL1 of the genes encoding Cyclin D1 and c-Myc may 
also lead to modulation of the cell cycle. Two other circadian clock 
proteins, PER1 and TIM, seem implicated in the DNA-damage re-
sponse because both can be found complexed with the ATM and ATR 
kinases and the checkpoint kinases Chk2 and Chk1, respectively. The 
dashed line between TIM and PER1 represents the functional link that 
exist between these two classes of proteins in various species. We 
favor a view in which posttranslational modifications of key proteins 
would govern the functional links between the circadian clock and the 
cell-cycle machinery. These would therefore likely be “opportunistic” 
and episodic rather than operating at all times.Cell 129, May 4, 2007 ©2007 Elsevier Inc. 463
the molecular pathways by which PER2 exerts its func-
tion in tumor suppression remain to be elucidated, the 
physical interaction of PER1 with ATM and Chk1 men-
tioned above (Gery et al., 2006) is highly suggestive of 
common pathways that could help the cell in responding 
to environmental hazards that may affect genomic sta-
bility. Although PER1 and PER2 seem to play distinct cir-
cadian clock functions in a normal physiological setting, 
it is conceivable that they may act in concert in response 
to pathological situations.
How can some clock proteins play a dual role, in the 
control of both circadian and cell cycles? A molecular 
switch is likely to occur that could involve the preferen-
tial interaction with alternative sets of partner proteins, 
generating a dynamic transfer from a circadian control 
complex to a cell-cycle control complex. Whereas addi-
tional scenarios are of course conceivable, all are likely 
to involve intracellular signaling pathways through which 
clock and cell-cycle regulators are modified. The time-
table of the modification events is yet to be defined, but 
it is significant that many clock proteins are dynamically 
phosphorylated and that specific kinases have been 
directly implicated in circadian control.
Another level of regulation, tightly linked to phos-
phorylation, is intimately responsible for the oscillatory 
nature of circadian and cell-cycle clocks: protein degra-
dation and stability. A large body of evidence exists con-
cerning the central role played by the proteasome and 
the ubiquitin pathways in the cell cycle, and a number of 
studies in animals and fungi have shown the importance 
of proteasomal protein turnover of clock proteins to cir-
cadian rhythms. However, the extent to which the cir-
cadian clock uses the cell cycle proteasome machinery 
as a means of regulation is less known. One significant 
finding is related to Slimb, a F box ubiquitin ligase that 
controls the levels of the PER and TIM proteins in the fly 
(Grima et al., 2002; Ko et al., 2002). This level of control 
seems to be a conserved feature because the mamma-
lian F box proteins β-TRCP1 and β-TRCP2, orthologs 
of the Drosophila Slimb protein, appear to preside the 
same function (Shirogane et al., 2005). A fascinating 
facet of deciphering the proteasome effectors that regu-
late the circadian clock is that they may constitute a yet 
uncharacterized set and would thereby identify alterna-
tive molecular pathways in the control of protein degra-
dation and stability.
Cycles and Human Health
An impressive array of syndromes and disturbancies, 
including sleep disorders, depression, and endocrine 
unbalances, are related to the misfunctioning of the cir-
cadian clock apparatus. More related to the subject at 
hand is the relationship with cancer. A simple but strik-
ing example of how profound circadian regulation influ-
ences human physiology is the increased susceptibility 
that shift workers have for some types of cancer. The 
intriguing links between circadian clock and cell cycle 
outlined here indicate that we have still a lot to learn 464 Cell 129, May 4, 2007 ©2007 Elsevier Inc.about how cells control their proliferation and growth, 
with obvious implications for the understanding of how 
pathological conditions may develop. For example, the 
accumulated evidence strongly indicates that more 
attention should be paid to the design of time schedules 
for cancer therapies (Fu and Lee, 2003). A remarkable 
number of descriptive studies indicate that the adminis-
tration of specific chemotherapies at one time of the day 
rather than another may have drastic effects on the clini-
cal outcome. Although the molecular understanding of 
these effects is still lacking, the unique features of some 
of the molecular interactions between clock proteins 
and cell-cycle controllers reported here pave the way for 
future pharmacological studies. These may open new 
avenues of therapeutical intervention that could have 
far-reaching consequences for human health.
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